Showing 1 - 7 results of 7 for search 'Laura Yerly (16509241)', query time: 0.01s
Refine Results
-
1
Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
2
Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
3
Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
4
Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
5
Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
6
Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”
-
7
Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer by Christine Pich-Bavastro (16509238)
Published 2025Other Authors: “…Laura Yerly (16509241)…”